Recent Posts
- Vaccitech Awarded BARDA contract valued at $8.5M to conduct Phase II trial for Influenza Vaccine
- Vaccitech receives £6M investment from GeneMatrix and Korea Investment Partners
- Update: INVICTUS Study
- Vaccitech licenses MERS rights to Oxford University: CEPI Awards Contract Worth Up To USD$19 million to Oxford University and Janssen Vaccines to Develop MERS, Lassa, and Nipah Vaccines
- New UK-China biotech collaboration to develop shingles vaccine